Emerging Technology Forum

1:00 PM - 6:00 PM Thursday, January 23

The Forum is designed to provide an interactive and dynamic platform for the review and discussion of emerging topics, informatics, technologies, clinical applications, and economic and regulatory issues impacting the development of emerging technologies. This event will showcase new and innovative companies in our ever-expanding field. The Forum will include discussions on a broad range of topics, including partnerships, funding strategies, FDA requirements, as well as the emerging global ecosystem for neuromodulation devices and patient selection.

Participating companies include IntraVu, Nia Therapeutics, Paradromics, and WISE Srl, among others.

  • Cash award and certificate for “Best in Show”
  • Opportunity for company exposure to industry figureheads and physician key opinion leaders
  • Opportunity to exhibit throughout the meeting to over 3000 members

The review panel will be populated by leading figures in Medtronic, Boston Scientific, Abbott, Nevro, and other influential companies in the field of neuromodulation.

This is a non-CME session.

Registration Rates:

On or before November 4, 2019: $125
After November 4, 2019: $175



Introduction to Neuromodulation and Marketplace

Ali Rezai, MD

Market Outlook and VC Funding Potential

James Cavuoto

Regulatory/Approval Environment

Peter Konrad, MD PhD

Panel Discussion

Company Selection Announcement

Jason Pope, MD


Break and Networking Session in Exhibit Hall

Company Presentations

Top 3 Companies – Presenting Company Announcement

Future Directions

Faculty and Presentations subject to change.

Company Application Form



James Cavuoto

Ali Rezai, MD

Peter Konrad, MD PhD

Course Directors:

Jason Pope, MD

Faculty subject to change.